logo-loader

Full interview: Algernon Announces Regulatory Submission for COVID trial in South Korea

Published: 16:25 09 Apr 2020 EDT

Algernon (CSE:AGN-OTCQB: AGNPF) CEO Christopher Moreau joined Steve Darling from Proactive Vancouver to discuss another development for their repurposed drug Ifenprodil. Moreau giving Proactive more details about the study which will consist of 40 patients and will deal with those currently sick with the coronavirus.

Poseidon Nickel signs binding agreement with Mineral Resources to divest...

Departing Poseidon Nickel Ltd (ASX:POS, OTC:PSDNF) CEO Craig Jones and incoming CEO Brendan Shalders join Proactive’s Jonathan Jackson to discuss the divestment of Lake Johnston to Mineral Resources Ltd (ASX:MIN). Jones, who has played a pivotal role in this strategic move, shared insights on...

3 hours, 55 minutes ago